Corrigendum to "Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia" J Clin Lipidol 11 (2017) 1338-1346

Affiliations

• ¹ Department of Clinical Genetics, Academic Medical Centre, Amsterdam, The Netherlands.
• ² Department of Molecular Medicine, Umberto I Hospital, 'Sapienza' University of Rome, Rome, Italy.
• ³ Lipid Clinic, Oslo University Hospital, Oslo, Norway.
• ⁴ School of Medicine, University of Utah, Salt Lake City, UT, USA.
• ⁵ Translational Medicine and Early Development, Sanofi, Frankfurt, Germany.
• ⁶ Sanofi, Montpellier, France.
• ⁷ Precision Medicine, Regeneron Pharmaceuticals, Inc, New York, NY, USA.
• ⁸ Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: [email protected].